ArticleBMC cancer2011

A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis.

Robert K Dearth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.